← Browse by Condition
Medical Condition

cervicogenic headache

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for cervicogenic headache sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cervicogenic headache Clinical Trials

How many clinical trials are currently recruiting for cervicogenic headache?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for cervicogenic headache, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cervicogenic headache?
cervicogenic headache research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cervicogenic headache clinical trial?
Eligibility criteria for cervicogenic headache trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
1
Top Sponsors
Michigan State University 1 trial
Foundation University Islamabad 1 trial
University of Lahore 1 trial
Beijing Tiantan Hospital 1 trial

Recruiting Clinical Trials

NCT05617365 Phase 1, Phase 2
Recruiting
Treating Chronic Cervicogenic Head and Neck Pain
Enrollment
30 pts
Location
United States
Sponsor
Michigan State University
View Trial →
NCT06731114
Recruiting
"Additional Effects of Sternocleidomastoid Release Along With Suboccipital Muscle Release in Management of Cervicogenic Headache'
Enrollment
54 pts
Location
Pakistan
Sponsor
Foundation University Islamaba...
View Trial →
NCT07163208
Recruiting
Therapeutic Efficacy of Different Wavelengths of Low-Level Laser Therapy in the Treatment of Cervicogenic Headache
Enrollment
150 pts
Location
Pakistan
Sponsor
University of Lahore
View Trial →
NCT07347730
Recruiting
Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Cervicogenic Headache
Enrollment
1,036 pts
Location
China
Sponsor
Beijing Tiantan Hospital
View Trial →

Related Conditions

neck pain posterior (1) myofascial trigger points (1) dorsal root ganglion (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology